Skip to content

Insights on the Global Veterinary Medicine Market to 2027

DUBLIN, July 15, 2022 /PRNewswire/ — The “Veterinary Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to’s offering.

The global veterinary medicine market reached a value of US$31.06 Billion in 2021. Looking forward, the publisher expects the market to reach a value of $48.58 Billion by 2027, exhibiting a CAGR of 7.74% during 2021-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Veterinary medicine is a branch of science that deals in the prevention, control, diagnosis, and treatment of diseases that affect the health of domestic and wild animals. It helps maintain the health of food-producing animals, inhibit the transmission of zoonotic diseases from animal species to humans, and ensure a safe supply of food worldwide. At present, the escalating consumption of animal-derived products is increasing the adoption of veterinary medicines to monitor the health of agricultural animals and prevent human exposure to diseases.

The growing trend of nuclear families and inflating income levels have increased the overall spending of individuals on pets globally. This, in confluence with the rising concerns among pet parents about the well-being of their pets, represents one of the major factors supporting the demand for veterinary medicines.

The increasing penetration of pet insurance is further influencing the market growth. Apart from this, the expanding animal husbandry activities, along with the escalating cases of zoonotic and chronic diseases among animals, are increasing the concerns about food safety. This, along with the increasing number of commercial animal-production programs, is promoting the adoption of veterinary medicines for better diagnosis and treatment for livestock.

Moreover, the easy availability of advanced diagnostic imaging, novel therapies, nuclear and regenerative medicines, laser diagnostics, and specialized surgeries in numerous vet hospitals and clinics is bolstering the market growth. Furthermore, biomedical researchers are developing safe and effective vaccines to prevent pet diseases, which is anticipated to strengthen the market growth.

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Archer-Daniels-Midland Company, Boehringer Ingelheim GmbH, Cargill Incorporated, Ceva Sante Animale, Dechra Pharmaceuticals PLC, Elanco Animal Health Incorporated, Evonik Industries AG, Merck & Co. Inc., Neogen Corporation, Vetoquinol SA, Virbac and Zoetis Inc.

Key Questions Answered in This Report:

  • How has the global veterinary medicine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary medicine market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the animal type?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary medicine market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Veterinary Medicine Market
5.1 Market Overview
5.2 MarketPerformance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Product
6.1 Drugs
6.1.1 Market trends
6.1.2 Key Segments Antiinfective Anti-inflammatory Parasiticide
6.1.3 Market Forecast
6.2 Vaccines
6.2.1 Market trends
6.2.2 Key Segments Inactivated Vaccines Attenuated Vaccines Recombinant Vaccines
6.2.3 Market Forecast
6.3 Medicated Feed Additives
6.3.1 Market trends
6.3.2 Key Segments Amino Acids Antibiotics
6.3.3 Market Forecast

7 Market Breakup by Animal Type
7.1 Production
7.1.1 Market trends
7.1.2 Market Forecast
7.2 Companion
7.2.1 Market trends
7.2.2 Market Forecast

8 Market Breakup by Route of Administration
8.1 Oral
8.1.1 Market trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market trends
8.2.2 Market Forecast
8.3 Topics
8.3.1 Market trends
8.3.2 Market Forecast

9 Market Breakup by Distribution Channel
9.1 Veterinary Hospitals and Clinics
9.1.1 Market trends
9.1.2 Market Forecast
9.2 Point-of-Care Testing/In-house Testing
9.2.1 Market trends
9.2.2 Market Forecast
9.3 Others
9.3.1 Market trends
9.3.2 Market Forecast

10 Market Breakup by Region

11 SWOT Analysis

12Value ChainAnalysis

13 Porters Five Forces Analysis

14 PriceAnalysis

15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Archer-Daniels-Midland Company Company Overview Product Portfolio Financials SWOT Analysis
15.3.2 Boehringer Ingelheim GmbH Company Overview Product Portfolio
15.3.3 Cargill Incorporated Company Overview Product Portfolio SWOT Analysis
15.3.4 Ceva Sante Animale Company Overview Product Portfolio
15.3.5 Dechra Pharmaceuticals PLC Company Overview Product Portfolio Financials
15.3.6 Elanco Animal Health Incorporated Company Overview Product Portfolio Financials
15.3.7 Evonik Industries AG Company Overview Product Portfolio Financials
15.3.8 Merck & Co. Inc. Company Overview Product Portfolio Financials
15.3.9 Neogen Corporation Company Overview Product Portfolio Financials SWOT Analysis
3.15.10 Vetoquinol SA Company Overview Product Portfolio Financials
3.15.11 Virbac Company Overview Product Portfolio Financials SWOT Analysis
3.15.12 Zoetis Inc. Company Overview Product Portfolio Financials SWOT Analysis

For more information about this report visit

Media Contact:

Research and Markets
Laura WoodSenior Manager
[email protected]

For EST Office Hours Call +1-917-300-0470
For US/CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

US Fax: 646-607-1904
Fax (outside US): +353-1-481-1716


SOURCE Research and Markets


Leave a Reply

Your email address will not be published.